Order Article Reprints

Amodio N, Gallo Cantafio ME, Botta C, Agosti V, Federico C, Caracciolo D, Ronchetti D, Rossi M, Driessen C, Neri A, et al. Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma. Cancers. 2019; 11(2):236. https://doi.org/10.3390/cancers11020236

Amodio, Nicola, Maria Eugenia Gallo Cantafio, Cirino Botta, Valter Agosti, Cinzia Federico, Daniele Caracciolo, Domenica Ronchetti, Marco Rossi, Christoph Driessen, Antonino Neri, and et al. 2019. "Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma" Cancers 11, no. 2: 236. https://doi.org/10.3390/cancers11020236

Amodio, N., Gallo Cantafio, M. E., Botta, C., Agosti, V., Federico, C., Caracciolo, D., Ronchetti, D., Rossi, M., Driessen, C., Neri, A., Tagliaferri, P., & Tassone, P. (2019). Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma. Cancers, 11(2), 236. https://doi.org/10.3390/cancers11020236